Bristol-Myers Squibb Co PEG Ratio
Data as of October 02, 2026
PEG Ratio
-7.62
PE Ratio (TTM)
13.54
EPS (TTM)
$4.54
Sector
Pharmaceuticals
How It's Calculated
-7.62 = 13.54 ÷ Growth Rate
What This Means
Bristol-Myers Squibb Co has a negative PEG ratio of -7.62, which typically means the company has negative earnings or a negative growth rate. PEG is not meaningful in this scenario.
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Co (BMY) operates in the Pharmaceuticals sector, specifically in Pharmaceuticals. With a market capitalization of about $125.72B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $61.46, within a 52-week range of $42.52 to $68.64 (-10.5% from the high, +44.5% from the low). Beta of 0.20 indicates relatively lower volatility versus the market.
Trailing profit margin is about 18.9%, signaling a solid profit margin for its industry.
Understanding This Metric
The PEG ratio adjusts the PE multiple for expected earnings growth, helping compare fast-growing and slow-growing names on a more equal footing. For Bristol-Myers Squibb Co, a PEG near 1 is often described as fairly valued relative to growth, though the growth estimate itself can change quickly with guidance revisions.
Sector Comparison
Among Pharmaceuticals names on our S&P 100 coverage, Bristol-Myers Squibb Co's PEG ratio of -7.62 can be compared with peers such as LLY (1.34), JNJ (2.42), MRK (2.90). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Pharmaceuticals stocks.
Key Takeaways
- BMY is grouped in the Pharmaceuticals sector for peer comparisons.
- Recent beta of 0.20 suggests lower-than-market price sensitivity.
- Trailing profit margin of 18.9% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for BMY.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other BMY Metrics
Frequently Asked Questions
What is BMY's PEG ratio?
PEG adjusts PE for expected earnings growth: PEG ≈ PE ÷ earnings growth rate. Bristol-Myers Squibb Co's PEG of -7.62 is a shorthand for growth-at-a-reasonable-price comparisons.
Does PEG suggest growth at a reasonable price?
PEG below 1.0 (-7.62) is often described as inexpensive relative to growth expectations — verify the growth input is realistic.
What are limitations of PEG for BMY?
PEG depends on a single growth estimate, ignores balance sheet risk, and can mislead when earnings are volatile. Use it with PE, margins, and Pharmaceuticals peers — not as a standalone verdict.
Calculate the peg ratio for any stock with our free calculator.
Open PEG Ratio Calculator →